The EU has published new funding calls – offering exciting opportunities for research- and innovation-driven companies in the healthcare sector. While the current Mission Cancer programme does not focus on therapy development which are relevant for companies, several other calls within the Health domain present greater potential: they address pressing medical challenges and offer substantial support for research and development projects. Particularly noteworthy is that some calls even allow for the funding of clinical studies up to and including Phase II.
This newsletter provides you with a concise overview of the current calls. Please note that these are single-stage application procedures with a submission deadline in September.
We are happy to support you with the scientific and technical drafting of your proposal, partner search, budget planning, and all formal requirements. Feel free to reach out to us – the initial consultation is, of course, free of charge and offers a great opportunity to explore the potential for your company. Read More…